"Because (neither) the manufacturer nor the pharmacy benefit manager who we contract with will work with us to get the cost down," said Folwell
(PubMed) Mullan K, Cardwell CR, McGuinness B, Woodside JV, McKay GJ
Novo Nordisk continues to promote and sell these products without any warning or discussion in their label regarding a risk of permanent vision loss. According to Gold, lawsuits allege that Novo Nordisk failed to warn patients and doctors about the risk of permanent blindness, even as new research found a significantly increased risk of NAION among semaglutide users
Goren A, et al
If your levels are within this range, it suggests that your current diet, lifestyle, and supplement routine are effectively supporting your cellular health
Similar guidance applies to those managing foods to avoid on GLP-1 medications